Clinical Trials
🇺🇸 FDA Page 25FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 289–300 of 380 articles
ACRP 2026: Immunology Updates and Clinical Research Trends
TransMedics Unveils New CHOPS Organ Preservation System at ISHLT 2026 Meeting
Alpha Tau Receives FDA Approval to Expand Alpha DaRT Pancreatic Cancer Trial with Gemcitabine-Abraxane Combination
Capricor Therapeutics HOPE-3 Phase 3 Trial Results for Deramiocel in Duchenne Muscular Dystrophy to be Presented at AAN 2026
FDA Guidance on Clinical Trial Transparency: What You Need to Know
NAFDAC Pediatric Clinical Trials: New Regulatory Requirements & Impact 2024
BBSW AI Solution Event: Pharma AI's Future Unveiled
OSE Immunotherapeutics' Tedopi Ovarian Cancer Trial Results Selected for ASCO 2026 Presentation
Nectero Therapeutics Reports Positive Two-Year Safety Data for EAST System in Abdominal Aortic Aneurysm Trial
Novo Nordisk's Oral Semaglutide Shows Promise as First GLP-1 Therapy for Children with Type 2 Diabetes
Neurosterix NTX-253 Schizophrenia Drug Phase 1 Trial on Track for Q2 2026 Completion
Greenwich LifeSciences GLSI-100 Abstract Accepted at ASCO 2026 for Breast Cancer Immunotherapy Trial